Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 2

Liczba wyników na stronie
first rewind previous Strona / 1 next fast forward last
Wyniki wyszukiwania
help Sortuj według:

help Ogranicz wyniki do:
first rewind previous Strona / 1 next fast forward last
EN
Acute pulmonary embolism (APE) is one of the main causes of cardiovascular deaths and anticoagulant treatment plays a key role in preventing recurrent episodes, chronic thromboembolic pulmonary hypertension (CTEPH), and deaths. The aim of this study is to assess the real-life trends and to determine factors associated with the choice of anticoagulation therapy in patients with APE. This is a single center prospective open study. We followed 178 consecutive patients admitted to the tertiary clinical center with APE proven with computed tomography (CT) scan within period of 24 months. A total number of 178 patients with APE were enrolled in the study. 48.9% of subjects were hospitalized in cardiology department. As a prolonged anticoagulant therapy 35.7% of study cohort received direct oral anticoagulants (DOACs), 35.1% LMWH, and 29.2% vitamin K antagonists (VKA), respectively. No statistically significant differences were found between the departments regarding frequency of prescribing anticoagulants (p=0.15). The multivariable analysis showed that oral anti-coagulants (OACs) were less likely to be prescribed than LMWH in patients with malignancy, history of major bleeding, serious medical condition and altered mental status. OACs were preferred over LMWH in symptoms of deep vein thrombosis (DVT). VKA were significantly less likely to be chosen than DOACs in patients with history of orthopaedics procedure. After six months anticoagulation therapy was discontinued in 24.3% of patients. Concluding, the form of anticoagulant therapy was associated with the presence of chronic diseases. LMWH was prescribed in high bleeding risk patients more frequently.
PL
Niniejszy artykuł jest poświęcony analizie jakości interfejsów wybranych bankowych aplikacji mobilnych. W trakcie badań brano pod uwagę czynniki takie jak bezpieczeństwo aplikacji, dostępność na platformy mobilne, szybkość wykonywania zadań, prostota obsługi, zrozumiałość, oprawa graficzna, komfort pracy, liczba funkcjonalności. W badaniach wykorzystane zostały badania ankietowe, testy korytarzowe, badania eksperckie oraz badania eyetrackingowe. Przeprowadzone eksperymenty ujawniły, że aplikacja T-Mobile Usług Bankowych przewyższa aplikację mBanku w kategoriach zrozumiałości, oraz prostoty obsługi. Aplikacja mBanku została lepiej oceniona pod względem responsywności, liczby funkcjonalności oraz dostępności.
EN
This paper is focused on comparison of interface quality of mobile access to the services of selected banks. Main factors, which were used in the comprising process are: safety, availability on the mobile platforms, time and simplicity of task performing, intelligibility, design, comfort, number of functions. Research was made using 4 methods: surveys, corridor tests, expert tests and eyetracking. As a result T-Mobile Banking Services won in three categories: intelligibility, design and simplicity while mBank is better in responsiveness, availability and has more functions to offer.
first rewind previous Strona / 1 next fast forward last
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.